~
查詢

PiVOT

PiVOT is a leading Contract Research Organization (CRO) in the Philippines. With over 100 years of aggregate employee experience in clinical research - from multinational companies like Pfizer, Novartis, Boehringer-Ingelheim, GlenEagles, PPD, and IQVIA (formerly Quintiles) - we obtained our license to operate from the Philippine Food and Drug Administration in 2018.
 
We are 100% owned by First Philippine Holdings Corp., a publicly-listed, Lopez-owned company, with assets of US$9B and attributable recurring net income of US$200M in power generation, real estate, construction, manufacturing, education, and healthcare.

Agilex Biolabs

Agilex Biolabs, as Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials specialises in both LC-MS/MS and immunoassay/immunobiology services. We operate a fully quality-assured, FDA-inspected laboratory in Australia (ISO/IEC17025 and OECD GLP), offering bioanalysis for small molecules and biologics for PK, PD, immunogenicity, and biomarkers as well as an immunobiology service for evaluation of immunological endpoints by flow cytometry and cell-based assays. Agilex Biolabs would like to engage biotech and pharma companies interested in utilising Australia as their early phase clinical trial location to access regulatory speed, R&D Tax cash-back incentives and premium quality service.

Berlin Partner for Business and Technology

A unique public-private partnership, Berlin Partner for Business and Technology collaborates with the Berlin State Senate and over 230 companies dedicated to promoting their city.

HTW Berlin, Zentrum für berufsbegleitendes und wei

HTW Berlin is the largest University of Applied Sciences in Berlin, Germany. The international MBA&E Life Science Management Programme offers ambitious professionals a stepping stone leveraging their career as a Life Science Manager.

Alira Health

Our global team delivers revolutionary solutions and unparalleled support to help clients set new standards of care. We guide growth and innovation across product and business lifecycles through a fully integrated suite of services that span the healthcare and life sciences ecosystem.

Exopharm Ltd

Exopharm is a clincial-stage Australian biotechnology company using exosomes (extracellular vesicles (EVs)) from cells to generate a new class of transformative medicines. The company’s proprietary EV engineering technologies enable improved loading of nucleic acid medicines into EVs, and allow EVs to be directed towards selected cell types. Together with its LEAP technology, which allows large-scale and economical isolation of exosomes, Exopharm is using combinations of its engneering technologies to develop a pipeline of EEV products for a range of clinical applications, including neurological diseases, infectious diseases, cancer and fibrosis.

Rommelag ENGINEERING

Rommelag is the inventor and global leader in Blow-Fill-Seal technology (BFS) which has been used to package liquid and semi-solid pharmaceutical products since the 1960’s. Our advanced aseptic process uses plastic polymer material to form, fill and hermetically seal a container in a highly integrated process. With the packaging of sterile liquids, gels, pastes and vaccines we serve the pharmaceutical, healthcare, cosmetic and chemical industries. Together with our customers, we develop innovative packaging solutions tailored precisely to their specific packaging task. We have customers in over 80 countries and more than 2,000 bottelpack systems in active use around the world.

EVERSANA

EVERSANA™ is the leading provider of global commercial services to the life sciences industry. Our integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. We serve more than 500 organizations, including innovative start-ups and established pharmaceutical companies to advance life science solutions for a healthier world.

基因泰克公司

基因泰克公司，全名基因工程科技公司(Genetic Engineering Technology)，是一家生物科技公司，由創投人羅伯特·史旺森與生物化學家赫伯特·博耶博士於1976年成立，這件事也被視為是生物科技產業的起點。2009年3月26日被瑞士羅氏製藥集團以468億美元全額收購。

鴻海精密工業股份有限公司(鴻海科技集團)

鴻海精密工業，簡稱鴻海精密、鴻海，是臺灣一家電子製造公司，也是鴻海科技集團的核心企業，由郭台銘於1974年創立。其中，健康科技事業群聚焦預防醫學及精準醫療等新興科技，服務範圍包括，食品安全檢測、健康管理中心及智能醫療解決方案等。

財團法人永齡健康基金會

永齡基金會自西元2000年創立，創辦人為鴻海科技集團總裁郭台銘先生，為其個人捐贈成立之基金會。「永齡」二字取自郭創辦人父母的名字各一字，以表飲水思源，百善孝為先的中華民族傳統。

永齡基金會就是在幫助「走在逆境中的人們」。我希望幫助他們，在逆境中把不可能變成可能。

CureVac N.V.

CureVac N.V.是一家臨床階段的德國生物製藥公司，開發基於mRNA技術的新型轉化藥物與療法。

我的公司未列在內，需要更新資訊？

聯繫環球生技»

生醫資料庫

熱門公司 查看更多

投資雷達 查看更多

公司說明會


TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務